References
- Pavlidis N, Pentheroudakis G. Cancer of unknown primary site. Lancet 2012;379:1428–35.
- Pavlidis N. Optimal therapeutic management of patients with distinct clinicopathological cancer of unknown primary subsets. Ann Oncol 2012;23(Suppl 10):x282–5.
- Taylor MB, Bromham NR, Arnold SE. Carcinoma of unknown primary: Key radiological issues from the recent National Institute for Health and Clinical Excellence guidelines. Br J Radiol 2012;85:661–71.
- Oien KA, Dennis JL. Diagnostic work-up of carcinoma of unknown primary: From immunohistochemistry to molecular profiling. Ann Oncol 2012;23(Suppl 10):x271–7.
- Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10–29.
- Bevier M, Sundquist J, Hemminki K. Incidence of cancer of unknown primary in Sweden: Analysis by location of metastasis. Eur J Cancer Prev 2012;21:596–601.
- Hemminki K, Bevier M, Hemminki A, Sundquist J. Survival in cancer of unknown primary site: Population-based analysis by site and histology. Ann Oncol 2012;23:1854–63.
- Golfinopoulos V, Pentheroudakis G, Salanti G, Nearchou AD, Ioannidis JP, Pavlidis N. Comparative survival with diverse chemotherapy regimens for cancer of unknown primary site: Multiple-treatments meta-analysis. Cancer Treat Rev 2009;35:570–3.
- Larsen IK, Smastuen M, Johannesen TB, Langmark F, Parkin DM, Bray F, et al. Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness. Eur J Cancer 2009;45:1218–31.
- Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982;38:933–42.
- Randén M, Rutqvist LE, Johansson H. Cancer patients without a known primary: Incidence and survival trends in Sweden 1960–2007. Acta Oncol 2009;48:915–20.
- Jerusalem G, Rorive A, Ancion G, Hustinx R, Fillet G. Diagnostic and therapeutic management of carcinoma of unknown primary: Radio-imaging investigations. Ann Oncol 2006;17(Suppl 10):x168–76.
- Bahrami A, Truong LD, Ro JY. Undifferentiated tumor: True identity by immunohistochemistry. Arch Pathol Lab Med 2008;132:326–48.
- Fizazi K, Greco FA, Pavlidis N, Pentheroudakis G, Group EGW. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow- up. Ann Oncol 2011;22(Suppl 6):vi64–8.
- Sagerup CM, Småstuen M, Johannesen TB, Helland Å, Brustugun OT. Sex-specific trends in lung cancer incidence and survival: A population study of 40,118 cases. Thorax 2011;66:301–7.